Friday, July 10, 2026

Patent intelligence · US

US 10668060

Tamper-resistant pharmaceutical compositions of opioids and other drugs

granted A61KA61K31/485A61K47/12A61K47/44
Status granted
Linked drugs 1
Pipeline programs 6
Years to expiry 14
Applicant portfolio 28
Patent details — US 10668060
Jurisdiction
US
Status
granted
Grant date
Jun 2, 2020
Expiration
May 28, 2040
Claims
17
CPC classes
A61K, A61K31/485, A61K47/12, A61K47/44
View on Google Patents ↗

Quick answer

US 10668060 (Tamper-resistant pharmaceutical compositions of opioids and other drugs) is held by Collegium Pharmaceutical, Inc.. Status: granted. Granted Jun 2, 2020. Expires May 28, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
17
CPC classes
A61K, A61K31/485, A61K47/12, A61K47/44, A61K9/14, A61K9/145

More from Collegium Pharmaceutical, Inc.

Related pharmaceutical patents in our USPTO index.

  1. US 11191758

    Use of selective serotonin 5-HT1A receptor agonists for treating side-effects of VMAT inhibitors

    Uniwersytet Jagiellonski Collegium Medicum · Expires Dec 2, 2041

    granted
  2. US 10646485

    Process of making stable abuse-deterrent oral formulations

    Collegium Pharmaceutical, Inc. · Expires May 7, 2040

    granted
  3. US 10525052

    Abuse-deterrent drug formulations

    Collegium Pharmaceutical, Inc. · Expires Jan 2, 2040

    granted
  4. US 10525053

    Abuse-deterrent pharmaceutical compositions of opioids and other drugs

    Collegium Pharmaceutical, Inc. · Expires Jan 2, 2040

    granted
  5. US 10188644

    Process of making stable abuse-deterrent oral formulations

    Collegium Pharmaceutical, Inc. · Expires Jan 24, 2039

    granted
  6. US 10004729

    Tamper-resistant pharmaceutical compositions of opioids and other drugs

    Collegium Pharmaceutical, Inc. · Expires Jun 21, 2038

    granted
  7. US 9968598

    Process of making stable abuse-deterrent oral formulations

    Collegium Pharmaceutical, Inc. · Expires May 10, 2038

    granted

Frequently asked questions

What is US patent 10668060?

US 10668060 (Tamper-resistant pharmaceutical compositions of opioids and other drugs) is held by Collegium Pharmaceutical, Inc.. Status: granted. Granted Jun 2, 2020. Expires May 28, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 10668060?

Collegium Pharmaceutical, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 28 pharmaceutical patents for this assignee.

When does US 10668060 expire?

Our index shows an expiration date of May 28, 2040 (14 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.